Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Uncover which travel rewards program is best suited for your needs. Make the most of your rewards and enhance your travel experience.
23,083 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
As Fed policy shifts and market volatility persists, analysts say the era of an automatic market backstop is fading. ...
Roughly 1 in 10 Medicare Advantage enrollees will lose their current plan for 2026 as insurers retreat from markets. ...
A new Fed chair can ripple through markets, but panic isn’t the right play. This article breaks down why chairman kev...
Sarah Jessica Parker’s journey from a large, struggling family to a $200 million fortune highlights how grit and ambi...
Sunrun jumped on news of a large-scale virtual power plant deal with Tesla and Renew Home, signaling a shift in distr...
Pump.fun has unveiled a record-setting compensation package for its Chief Legal Officer, signaling a competitive push...
Today's market action centers on semiconductor chatter, a solid Micron after-hours surge, and a mixed read across maj...
Two defendants, Real Brokerage and The Frano Team, were voluntarily dismissed without prejudice from the Taylor RESPA...
A private equity buyer has acquired the publishing stake in two Taylor Swift co-written hits, signaling a new frontie...
american giving $617 billion in 2025 rose 3%, signaling a record year for philanthropy. The Paul Allen effect exposes...
OpenAI's planned IPO faces a timing change that could redefine AI stock bets. The shift underscores a tougher funding...